Research
Energy balance
Glucagon coagonists like survodutide and mazdutide have demonstrated significant weight loss and improved glycemic control.
These agents may be effective options for patients needing weight loss and glycemic control.
StrongSupportsmedium confidence
Glucagon coagonists like survodutide and mazdutide have demonstrated significant weight loss and improved glycemic control.
Why this rating
The abstract provides direct claims about the efficacy of these agents.
Source
Novel GLP-1-based Medications for Type 2 Diabetes and Obesity
Jang Won Son et al. · Endocrine Reviews · 2025
DOI 10.1210/endrev/bnaf036
reviewCited 17×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →